Intelligent Bone Regeneration Technology
-
Regulatory
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
New Suture Anchors, Industry’s First U.S.-Cleared Non-Permanent Compression Staples and Additional Compression Screws to Join Previously Launched Products That Leave…
Read More » -
Extremities
OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for OSSIOfiberTM Intelligent Bone Regeneration Technology
Woburn, Mass., June 11, 2019 – OSSIO, Inc., an orthopedic fixation company, announced today that its OSSIOfiberTM Intelligent Bone Regeneration…
Read More » -
Extremities
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber™ Bone Pin Product Family
January 14, 2019 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, an orthopedic fixation company, today announced that its OSSIOfiber™ BonePin Family has received 510(k)…
Read More »